Benjamin Moosavi, MD
Plastic and Reconstructive Surgery · Huntington, WVNPI 1801000906
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by Hologic Inc at 37.6% of the total. Reporting peaked in 2022 at $6,544 and has fallen 90.5% since, to $620 in 2025.
Across 206 payments — averaging $84.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Inc$7K
- AbbVie$6K
- Focal Therapeutics, Inc.$2K
- Sientra, Inc.$970
- Mentor Worldwide LLC$518
- Galderma Laboratories, L.p.$184
- plus $1K from 34 others
Across 2 payments — averaging $35.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$70
What the payments were for
- Consulting fees$8,10147%
- Speaking & faculty fees$2,12012%
- Travel & lodging$1,6229%
- Food & beverage$5,46532%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic and reconstructive surgery providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 59 | $292 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $172 |
| Clindamycin Hcl | 14 | $120 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $78 |
| Ondansetron Hcl | 25 | $55 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Huntington
- Kamran AbolmaaliHuntington$3K
- Phillip LackeyHuntington$3K
- John HayesCharleston$65K
- Justin McKinneyCharleston$28K
- Jack BurnsCharleston$7K
- William RossCharleston$4K
- Marjorie BushWheeling$1K
- Karl MuellerWheeling$707
- Ronald LuethkeBridgeport$357
- Daniel WoodCharleston$279
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.